ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 618332 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 618332; 2) Community: the network communities that were significantly associated with the response to NSC 618332; 3) Molecule: the relationships between components within communities and NSC 618332; 4) MDR: the compounds that were significantly associated with the NSC 618332.

NSC Compound Enrichment Correlation
NSC 686368 Quinazolin-4(3H)-one, 3-ethyl- 2-[[[5-(phenylamino)-1,3,4-thiadiazol-2-yl]methyl]thio]- 0.0303322639291196 -0.1706648
NSC 693813 Null 0.0303322639291196 0.37228298
NSC 746149 N,N'-bis(4-bromo-2-fluorobenzoyl)-L-selenocystine bis(4-methoxyphenacyl) ester hemihydrate 0.0303322639291196 -0.072517265
NSC 108165 CP 12252-1 0.0303322639291198 0.19825202
NSC 616511 Null 0.0303322639291198 -0.054279808
NSC 19441 FDA 0283 0.0337307532806863 0.22705867
NSC 34475 Androst-5-en-16.beta.-ol, 3.beta.-methoxy- (8CI) 0.0337307532806863 0.18333722
NSC 34780 Null 0.0337307532806863 -0.043382471
NSC 48006 WLN: T6N CNJ DZ EF F- BT5OTJ EO1 0.0337307532806863 0.045884052
NSC 50273 Pyridine, 3-[[4-[bis(2-chloroethyl)amino]-2-methylbenzylidene]amino]- 0.0337307532806863 -0.051287932
Total:47  Current:29    [First] [Prev] [Next] [Last]